Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paraskevi Charalambatou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Radiation Protection Dosimetry|August 12, 2011
Patient-specific dosimetry in radionuclide therapyMaria Lyra, Nefeli Lagopati, Paraskevi Charalambatou, et al.
Hellenic Journal of Nuclear Medicine|April 23, 2011
Alternative production methods to face global molybdenum-99 supply shortageMaria Lyra, Paraskevi Charalambatou, Eirini Roussou, et al.
Plos One|August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212PbVincent Boudousq, Laure Bobyk, Muriel Busson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Radiation Protection Dosimetry|August 12, 2011
Patient-specific dosimetry in radionuclide therapyMaria Lyra, Nefeli Lagopati, Paraskevi Charalambatou, et al.
Hellenic Journal of Nuclear Medicine|April 23, 2011
Alternative production methods to face global molybdenum-99 supply shortageMaria Lyra, Paraskevi Charalambatou, Eirini Roussou, et al.
Plos One|August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212PbVincent Boudousq, Laure Bobyk, Muriel Busson, et al.
Pageof 1